(Q33419399)

26 July 2017

title

A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients (English)

1 reference

26 July 2017

1 reference

Rhett P Ketterling

7

0 references

Ayalew Tefferi

8

object named as

Ayalew Tefferi

1 reference

26 July 2017

Emnet Wassie

1

1 reference

26 July 2017

Christy Finke

2

1 reference

26 July 2017

Naseema Gangat

3

1 reference

26 July 2017

Terra L Lasho

4

1 reference

26 July 2017

Animesh Pardanani

5

1 reference

26 July 2017

Curtis A Hanson

6

1 reference

26 July 2017

language of work or name

English

0 references

publication date

17 December 2014

1 reference

British Journal of Haematology

26 July 2017

published in

1 reference

26 July 2017

volume

169

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

71-76

1 reference

IDH mutations and trisomy 8 in myelodysplastic syndromes and acute myeloid leukemia

26 July 2017

cites work

1 reference

Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients

21 January 2018

1 reference

The efficacy of direct, 24-hour culture, and mitotic synchronization methods for cytogenetic analysis of bone marrow in neoplastic hematologic disorders

21 January 2018

1 reference

DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status

21 January 2018

1 reference

Somatic mutations of calreticulin in myeloproliferative neoplasms

21 January 2018

1 reference

Cytogenetic studies and their prognostic contribution in 565 Chinese patients with primary myelofibrosis.

21 January 2018

1 reference

JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders.

21 January 2018

1 reference

Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasms.

21 January 2018

1 reference

New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge

21 January 2018

1 reference

Cytogenetic Nomenclature: Changes in the ISCN 2013 Compared to the 2009 Edition

21 January 2018

1 reference

Predictors of greater than 80% 2-year mortality in primary myelofibrosis: a Mayo Clinic study of 884 karyotypically annotated patients.

21 January 2018

1 reference

CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

21 January 2018

1 reference

Mutations and prognosis in primary myelofibrosis

21 January 2018

1 reference

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.13260

1 reference

26 July 2017

1 reference